Bath & Body Works Launches Fragrance Collection Inspired by Disney Villains
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 18 2025
0mins
Should l Buy BBWI?
Source: Newsfilter
New Fragrance Collection Launch: Bath & Body Works is introducing The Disney Villains Collection, featuring fragrances inspired by iconic Disney villains, The Evil Queen and Maleficent, due to high consumer demand following the success of their Disney Princess Collection.
Global Availability: This collection will be available simultaneously in both domestic and international stores, allowing Disney fans worldwide to experience the new fragrances starting September 3, 2025, with early access for loyalty members on August 26 and 27.
Fragrance Details: The collection includes 39 products such as fine fragrance mist, body wash, candles, and more, with scents designed to reflect the characters' personalities—The Evil Queen's fragrance features dark red apple and vanilla suede, while Maleficent's includes sinister plum and midnight berries.
Strategic Partnership: Bath & Body Works and Disney are strengthening their collaboration to create culturally resonant products that enhance consumer engagement, with plans for future collections featuring more iconic Disney characters.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BBWI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BBWI
Wall Street analysts forecast BBWI stock price to fall
14 Analyst Rating
4 Buy
10 Hold
0 Sell
Moderate Buy
Current: 23.910
Low
15.00
Averages
20.14
High
26.00
Current: 23.910
Low
15.00
Averages
20.14
High
26.00
About BBWI
Bath & Body Works, Inc. is a global omnichannel retailer focused on personal care and home fragrance. The Company offers a range of fragrances for the body and home, including selling collections for 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions and body creams. It delivers customers their fragrances in multiple forms and categories. The Company sells merchandise through its retail stores in the United States and Canada, and through its Websites and other channels, under the Bath & Body Works, White Barn and other brand names. The Company’s international business is conducted through franchise, license and wholesale partners. It provides in-store experiences at more than 1,890 Company-operated Bath & Body Works locations in the United States and Canada, more than 525 international franchised locations and an online storefront at bathandbodyworks.com. Additionally, it offers a buy online pick-up in-store (BOPIS) option.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Bath & Body Works Faces Continued Sales Declines Amid Strategy Shift
- Downgrade in Expectations: Citi Research analyst Paul Lejuez downgraded Bath & Body Works (BBWI) from Buy to Neutral, anticipating a fifth consecutive year of sales declines due to persistent weaknesses in its core business, particularly highlighted by the disappointing Disney collaboration that negatively impacted Q3 results.
- Pessimistic Sales Guidance: Citi expects BBWI's FY26 EPS guidance to range between $2.10 and $2.25, falling short of the consensus estimate of $2.50, with current quarter sales projected to decline in the mid-single digits to high single digits, indicating significant market pressures.
- Strategic Market Shift: CEO Daniel Heaf indicated a shift towards partnerships to enhance market share, which, while potentially boosting online sales, may further erode in-store traffic as customers find online shopping more convenient.
- Innovation and Leadership Concerns: Although the new leadership is expected to revitalize the core business through product innovation, analysts express concerns about the effectiveness of this strategy in driving a sales turnaround by 2026, suggesting that reliance on price promotions to stimulate demand may not be sustainable in the short term.
See More
High Options Trading Volume for Bath & Body Works and Accenture
- Bath & Body Works Options Activity: Bath & Body Works Inc (BBWI) saw options trading volume of 20,407 contracts today, representing approximately 2 million shares, which is about 44% of its average daily trading volume of 4.6 million shares over the past month, indicating heightened market interest in the stock.
- High Volume Contracts: Notably, the $20 strike call option for BBWI has seen particularly high activity, with 8,640 contracts traded today, representing approximately 864,000 underlying shares, reflecting investor optimism regarding potential price increases in the future.
- Accenture Options Dynamics: Similarly, Accenture plc (ACN) has shown strong options trading volume of 24,709 contracts, equating to about 2.5 million shares, also accounting for 44% of its average daily trading volume of 5.6 million shares over the past month, suggesting a positive outlook from the market.
- Key Contract Analysis: For ACN, the $250 strike put option has recorded a trading volume of 7,211 contracts, representing approximately 721,100 underlying shares, indicating investor concern over potential downside risks, which could impact its stock price trajectory.
See More
Bath & Body Works Faces Class Action Lawsuit
- Lawsuit Reminder: The Schall Law Firm reminds investors of a class action lawsuit against Bath & Body Works for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between June 4, 2024, and November 19, 2025, with a deadline to contact the firm by March 16, 2026, for participation.
- False Statements: The complaint alleges that Bath & Body Works made false and misleading statements during the class period, claiming that its strategy of seeking 'adjacencies, collaborations, and promotions' would grow its customer base and net sales, which ultimately failed to materialize.
- Weak Financial Performance: The company resorted to brand collaborations to 'carry quarters' despite weak financial results, indicating that its public statements were false and materially misleading throughout the class period, leading to investor losses when the truth emerged.
- Legal Consultation Opportunity: The Schall Law Firm offers free consultations and encourages affected investors to reach out to discuss their rights, emphasizing its specialization in securities class action lawsuits and shareholder rights litigation aimed at helping investors recover losses.
See More
Investigation into Bath & Body Works Securities Litigation Announced
- Legal Investigation: Faruq & Faruqi LLP is investigating potential securities fraud claims against Bath & Body Works (NYSE: BBWI) and is encouraging investors who purchased securities between June 4, 2024, and November 19, 2025, to contact them to discuss their legal rights.
- Declining Financial Performance: In Q3 2025, Bath & Body Works reported a 1% year-over-year decline in revenue, missing prior guidance of 1-3% growth, and a 26% drop in net income to $77 million, indicating a failure in its business strategy.
- Admission of Strategic Failures: The company acknowledged in an investor presentation that its focus on
See More
Shareholder Notice for Bath & Body Works Class Action
- Lawsuit Background: Shareholders of Bath & Body Works (BBWI) are encouraged to contact Gross Law Firm regarding potential lead plaintiff status for the class period from June 4, 2024, to November 9, 2025, indicating significant legal challenges that may impact shareholder confidence.
- False Statement Allegations: The lawsuit alleges that during the class period, the company issued materially misleading statements and failed to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, leading to net sales growth falling short of expectations, which could affect future performance.
- Financial Guidance Missteps: As the company relied on brand collaborations to mask weak financial results, the lawsuit claims it is unlikely to meet its previously issued financial guidance, potentially diminishing investor confidence in the company's future.
- Shareholder Action Steps: Shareholders must register by March 13, 2026, to participate in the lawsuit, and upon registration, they will receive updates on the case's progress, reflecting the uncertainty surrounding the company's legal issues that may affect its stock performance.
See More
Class Action Notice for Bath & Body Works Investors
- Class Action Initiation: Rosen Law Firm reminds investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiffs by March 16, 2026, or risk losing their opportunity for compensation.
- Transparent Fee Structure: Investors participating in the class action will not incur any upfront costs, as the law firm operates on a contingency fee basis, which alleviates financial burdens and encourages broader participation in the claims process.
- Overview of Allegations: The lawsuit alleges that Bath & Body Works made materially misleading statements during the class period, failing to disclose that its market strategies were not achieving expected customer and sales growth, resulting in investor losses and highlighting serious issues with the company's financial health.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating its extensive experience and success in handling such cases, which investors should consider when selecting legal counsel.
See More
Bath & Body Works Faces Continued Sales Declines Amid Strategy Shift
- Downgrade in Expectations: Citi Research analyst Paul Lejuez downgraded Bath & Body Works (BBWI) from Buy to Neutral, anticipating a fifth consecutive year of sales declines due to persistent weaknesses in its core business, particularly highlighted by the disappointing Disney collaboration that negatively impacted Q3 results.
- Pessimistic Sales Guidance: Citi expects BBWI's FY26 EPS guidance to range between $2.10 and $2.25, falling short of the consensus estimate of $2.50, with current quarter sales projected to decline in the mid-single digits to high single digits, indicating significant market pressures.
- Strategic Market Shift: CEO Daniel Heaf indicated a shift towards partnerships to enhance market share, which, while potentially boosting online sales, may further erode in-store traffic as customers find online shopping more convenient.
- Innovation and Leadership Concerns: Although the new leadership is expected to revitalize the core business through product innovation, analysts express concerns about the effectiveness of this strategy in driving a sales turnaround by 2026, suggesting that reliance on price promotions to stimulate demand may not be sustainable in the short term.
See More
High Options Trading Volume for Bath & Body Works and Accenture
- Bath & Body Works Options Activity: Bath & Body Works Inc (BBWI) saw options trading volume of 20,407 contracts today, representing approximately 2 million shares, which is about 44% of its average daily trading volume of 4.6 million shares over the past month, indicating heightened market interest in the stock.
- High Volume Contracts: Notably, the $20 strike call option for BBWI has seen particularly high activity, with 8,640 contracts traded today, representing approximately 864,000 underlying shares, reflecting investor optimism regarding potential price increases in the future.
- Accenture Options Dynamics: Similarly, Accenture plc (ACN) has shown strong options trading volume of 24,709 contracts, equating to about 2.5 million shares, also accounting for 44% of its average daily trading volume of 5.6 million shares over the past month, suggesting a positive outlook from the market.
- Key Contract Analysis: For ACN, the $250 strike put option has recorded a trading volume of 7,211 contracts, representing approximately 721,100 underlying shares, indicating investor concern over potential downside risks, which could impact its stock price trajectory.
See More
Bath & Body Works Faces Class Action Lawsuit
- Lawsuit Reminder: The Schall Law Firm reminds investors of a class action lawsuit against Bath & Body Works for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between June 4, 2024, and November 19, 2025, with a deadline to contact the firm by March 16, 2026, for participation.
- False Statements: The complaint alleges that Bath & Body Works made false and misleading statements during the class period, claiming that its strategy of seeking 'adjacencies, collaborations, and promotions' would grow its customer base and net sales, which ultimately failed to materialize.
- Weak Financial Performance: The company resorted to brand collaborations to 'carry quarters' despite weak financial results, indicating that its public statements were false and materially misleading throughout the class period, leading to investor losses when the truth emerged.
- Legal Consultation Opportunity: The Schall Law Firm offers free consultations and encourages affected investors to reach out to discuss their rights, emphasizing its specialization in securities class action lawsuits and shareholder rights litigation aimed at helping investors recover losses.
See More
Investigation into Bath & Body Works Securities Litigation Announced
- Legal Investigation: Faruq & Faruqi LLP is investigating potential securities fraud claims against Bath & Body Works (NYSE: BBWI) and is encouraging investors who purchased securities between June 4, 2024, and November 19, 2025, to contact them to discuss their legal rights.
- Declining Financial Performance: In Q3 2025, Bath & Body Works reported a 1% year-over-year decline in revenue, missing prior guidance of 1-3% growth, and a 26% drop in net income to $77 million, indicating a failure in its business strategy.
- Admission of Strategic Failures: The company acknowledged in an investor presentation that its focus on
See More
Shareholder Notice for Bath & Body Works Class Action
- Lawsuit Background: Shareholders of Bath & Body Works (BBWI) are encouraged to contact Gross Law Firm regarding potential lead plaintiff status for the class period from June 4, 2024, to November 9, 2025, indicating significant legal challenges that may impact shareholder confidence.
- False Statement Allegations: The lawsuit alleges that during the class period, the company issued materially misleading statements and failed to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, leading to net sales growth falling short of expectations, which could affect future performance.
- Financial Guidance Missteps: As the company relied on brand collaborations to mask weak financial results, the lawsuit claims it is unlikely to meet its previously issued financial guidance, potentially diminishing investor confidence in the company's future.
- Shareholder Action Steps: Shareholders must register by March 13, 2026, to participate in the lawsuit, and upon registration, they will receive updates on the case's progress, reflecting the uncertainty surrounding the company's legal issues that may affect its stock performance.
See More
Class Action Notice for Bath & Body Works Investors
- Class Action Initiation: Rosen Law Firm reminds investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiffs by March 16, 2026, or risk losing their opportunity for compensation.
- Transparent Fee Structure: Investors participating in the class action will not incur any upfront costs, as the law firm operates on a contingency fee basis, which alleviates financial burdens and encourages broader participation in the claims process.
- Overview of Allegations: The lawsuit alleges that Bath & Body Works made materially misleading statements during the class period, failing to disclose that its market strategies were not achieving expected customer and sales growth, resulting in investor losses and highlighting serious issues with the company's financial health.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating its extensive experience and success in handling such cases, which investors should consider when selecting legal counsel.
See More
